Cited by 90Nutrition and Health in AgingDementia and Cognitive Impairment ResearchFrailty in Older Adults

Sarcopenic obesity and cognitive performance

Open access
Tolea, Magdalena, Chrisphonte, Stephanie, Galvin, James·2018·Clinical Interventions in Aging

Abstract

Background: Sarcopenia and obesity both negatively impact health including cognitive function. Their coexistence, however, can pose an even higher threat likely surpassing their individual effects. We assessed the relationship of sarcopenic obesity with performance on global- and subdomain-specific tests of cognition. Patients and methods: The study was a cross-sectional analysis of data from a series of community-based aging and memory studies. The sample consisted of a total of 353 participants with an average age of 69 years with a clinic visit and valid cognitive (eg, Montreal Cognitive Assessment, animal naming), functional (eg, grip strength, chair stands), and body composition (eg, muscle mass, body mass index, percent body fat) measurements. Results: Sarcopenic obesity was associated with the lowest performance on global cognition (Est. Definition1 =−2.85±1.38, p =0.039), followed by sarcopenia (Est. Definition1 =−1.88±0.79, p =0.017) and obesity (Est. Definition1 =−1.10±0.81, p =0.175) adjusted for sociodemographic factors. The latter, however, did not differ significantly from the comparison group consisting of older adults with neither sarcopenia nor obesity. Subdomain-specific analyses revealed executive function (Est. Definition1 =−1.22±0.46 for sarcopenic obesity; Est. Definition1 =−0.76±0.26 for sarcopenia; Est. Definition1 =−0.52±0.27 for obesity all at p 0.05) and orientation (Est. Definition1 =0.59±0.26 for sarcopenic obesity; Est. Definition1 =−0.36±0.15 for sarcopenia; Est. Definition1 =−0.29±0.15 all but obesity significant at p <0.05) as the individual cognitive skills likely to be impacted. Potential age-specific and depression effects are discussed. Conclusion: Sarcopenia alone and in combination with sarcopenic obesity can be used in clinical practice as indicators of probable cognitive impairment. At-risk older adults may benefit from programs addressing loss of cognitive function by maintaining/improving strength and preventing obesity. Keywords: sarcopenia, obesity, sarcopenic obesity, cognition, cross-sectional studies

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/cia.s164113

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Sarcopenic obesity is an indicator of probable cognitive impairment in the geriatric population.

    “A cross-sectional study has evaluated the association between SO and cognitive function in geriatric population, and found that SO is an indicator of probable cognitive impairment (65).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 56 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [47]Lezak MD Howieson DB Bigler ED Tranel D Neuropsychological Assessment 5th ed New York Oxford University Press 2012

Cited by

Sorted by citations

Authors
Tolea, M., Chrisphonte, S., & Galvin, J.
Affiliations
Florida Atlantic University (US)
Corresponding author
Tolea, Magdalena
Venue
Clinical Interventions in Aging
Published
2018-06
Volume
Volume 13
Pages
1111-1119
ISSN
  • 1176-9092 (ISSN-L)
  • 1178-1998
OpenAlex
W2806859832
Cited by
90
References
56
Citations by year
2026: 11 · 2025: 10 · 2024: 9 · 2023: 12 · 2022: 14 · 2021: 13 · 2020: 16 · 2019: 3 · 2018: 2
FWCI
5.84
Type
journal article
Language
en
Open access
Locations
  • Clinical Interventions in Aging (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
  • New York State Department of Health
  • Morris and Alma Schapiro Fund
  • National Institutes of Health (AG008051)
  • National Institute on Aging (P30AG008051, R01AG040211)
Topics
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
Keywords
sarcopenic obesity, sarcopenia, obesity, cognitive function, executive function, orientation, older adults, cognitive impairment, grip strength, body composition, muscle mass, Montreal Cognitive Assessment
MeSH terms
Aged, Body Composition, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, New York City, Obesity, Body Mass Index, Sarcopenia, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review